Literature DB >> 27320730

miR-197: A novel biomarker for cancers.

Dan-Dan Wang1, Xiu Chen2, Dan-Dan Yu3, Su-Jin Yang2, Hong-Yu Shen2, Huan-Huan Sha2, Shan-Liang Zhong4, Jian-Hua Zhao4, Jin-Hai Tang5.   

Abstract

microRNAs (miRNAs) are small noncoding RNAs that could regulate post-transcription level through binding to 3' untranslated region (3'UTR) of target messenger RNAs (mRNAs), which were reported to be related with the incidence and development of diverse neoplasms. Among them, miR-197 was confirmed to play a vital role of oncogene or anti-oncogene in different cancers via targeting key tumorigenic or tumor-suppressive genes. Additionally, miR-197 had extensively been studied in carcinogenesis progression of cancers through various mechanisms, including apoptosis, proliferation, angiogenesis, metastasis, drug resistance and tumor suppressor, and also played a role in prognosis of cancers. In this review, we summarized the roles of miR-197 in cancers and considered it as a potentially novel biomarker for different cancers, offering an alternatively secure and effective tool in molecular targeting cancer treatment.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; MicroRNA; miR-197

Mesh:

Substances:

Year:  2016        PMID: 27320730     DOI: 10.1016/j.gene.2016.06.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

Review 1.  Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.

Authors:  Francesco Prete; MariaTeresa Rotelli; Alessandro Stella; Giovanna Calculli; Lucia Ilaria Sgaramella; Antonio Amati; Nicoletta Resta; Mario Testini; Angela Gurrado
Journal:  Clin Exp Med       Date:  2022-08-01       Impact factor: 5.057

2.  CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer.

Authors:  Yue Shi; Tao Han; Chong Liu
Journal:  Ann Transl Med       Date:  2021-08

3.  Downregulation of hsa_circ_0006220 and its correlation with clinicopathological factors in human breast cancer.

Authors:  Chong Liu; Mingshi Chen; Yue Shi
Journal:  Gland Surg       Date:  2021-02

4.  Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study.

Authors:  Céline Bouvy; Adeline Wannez; Fabienne George; Carlos Graux; Christian Chatelain; Jean-Michel Dogné
Journal:  Biomark Cancer       Date:  2018-06-18

Review 5.  The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside.

Authors:  Michał Ciebiera; Marta Włodarczyk; Stanisław Zgliczyński; Tomasz Łoziński; Klaudia Walczak; Artur Czekierdowski
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

6.  Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.

Authors:  Yuan Yuan; Xiaogang Chen; Enying Huang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

7.  Circulating microRNA-197-3p as a potential biomarker for asbestos exposure.

Authors:  Francesca Frontini; Ilaria Bononi; Elena Torreggiani; Giulia Di Mauro; Elisa Mazzoni; Mariarita Stendardo; Piera Boschetto; Roberta Libener; Roberto Guaschino; Federica Grosso; Giovanni Guerra; Fernanda Martini; Mauro Tognon
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

8.  miR-197 Participates in Lipopolysaccharide-Induced Cardiomyocyte Injury by Modulating SIRT1.

Authors:  Miaomiao Liu; Ying Zhang; Xiantong Cao; Tao Shi; Yang Yan
Journal:  Cardiol Res Pract       Date:  2022-02-17       Impact factor: 1.866

9.  Identification of serum microRNA signatures associated with autism spectrum disorder as promising candidate biomarkers.

Authors:  Tatyana Kichukova; Veselin Petrov; Nikolay Popov; Danail Minchev; Samir Naimov; Ivan Minkov; Tihomir Vachev
Journal:  Heliyon       Date:  2021-07-03

Review 10.  MiR-29a: a potential therapeutic target and promising biomarker in tumors.

Authors:  Jin-Yan Wang; Qian Zhang; Dan-Dan Wang; Wei Yan; Huan-Huan Sha; Jian-Hua Zhao; Su-Jin Yang; He-da Zhang; Jun-Chen Hou; Han-Zi Xu; Yun-Jie He; Jia-Hua Hu; Shan-Liang Zhong; Jin-Hai Tang
Journal:  Biosci Rep       Date:  2018-02-08       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.